MAPK8 and Huntington disease: Key signalling molecules such as MAPK8 (JNK1) and JAK1/2 were unaffected in HD T lymphocytes, supporting our hypothesis that alternative signalling pathways are able to compensate for potential NFĸB pathway dysfunction.